0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Paul R. Lichter, MD
JAMA Ophthalmology
Original Investigation  | 
Physician-Industry Interactions and Anti–Vascular Endothelial Growth Factor Use Among US Ophthalmologists
Stanford C. Taylor, MD; Julia B. Huecker, MS; Mae O. Gordon, PhD; et al.
JAMA Ophthalmology
Ophthalmic Images  | 
Fernlike Maculopathy in a Patient With Central Retinal Vein Occlusion
Wai Kwan Lily Lai, MBBS, BSc; Mostafa A. Elgohary, MBChB, MSc, MD, FRCSEd, FRCSI, FRCOphth
JAMA Ophthalmology
Original Investigation  | 
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L. Ross, BA; David W. Hutton, PhD; Joshua D. Stein, MD, MS; et al.